Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study
Sofia Genta(Ente Ospedaliero Cantonale), Luca Ceriani(St Thomas' Hospital), Luciano Cascione(Institute of Oncology Research), Teresa Ruberto(Ente Ospedaliero Cantonale), Maria Cristina Pirosa(Institute of Oncology Research), Darius Juškevičius(University of Basel), Guido Ghilardi(Hospital of the University of Pennsylvania), Fabiana Esposito(Ente Ospedaliero Cantonale), Sämi Schär(Swiss Group For Clinical Cancer Research), Stefanie Hayoz(Swiss Group For Clinical Cancer Research), Luca Giovanella(University of Zurich), Christoph Mamot(Kantonsspital Aarau), Stefan Dirnhofer(University of Basel), Emanuele Zucca(Università della Svizzera italiana), Alexandar Tzankov(University of Basel), Lisa Milan(Ente Ospedaliero Cantonale)
Cited by 13
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
|Nature Medicine|2022|308
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
|Nature Medicine|2024|254